nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—Procarbazine—hematologic cancer	0.395	0.656	CrCrCtD
Baclofen—Ibuprofen—Melphalan—hematologic cancer	0.208	0.344	CrCrCtD
Baclofen—SLC22A8—Mercaptopurine—hematologic cancer	0.0291	0.754	CbGbCtD
Baclofen—SLC22A8—Methotrexate—hematologic cancer	0.00951	0.246	CbGbCtD
Baclofen—GABBR2—testis—hematologic cancer	0.0042	0.238	CbGeAlD
Baclofen—GABBR1—blood—hematologic cancer	0.00256	0.145	CbGeAlD
Baclofen—GABBR1—bone marrow—hematologic cancer	0.00248	0.14	CbGeAlD
Baclofen—GABBR1—lung—hematologic cancer	0.00225	0.127	CbGeAlD
Baclofen—GABBR1—testis—hematologic cancer	0.00212	0.12	CbGeAlD
Baclofen—GABBR1—lymph node—hematologic cancer	0.00154	0.0869	CbGeAlD
Baclofen—SLC22A8—hematopoietic system—hematologic cancer	0.00153	0.0864	CbGeAlD
Baclofen—SLC22A8—blood—hematologic cancer	0.00101	0.0572	CbGeAlD
Baclofen—Ibuprofen—BCL2—hematologic cancer	0.000675	0.385	CrCbGaD
Baclofen—Ibuprofen—UGT1A1—hematologic cancer	0.000574	0.328	CrCbGaD
Baclofen—Chlorpropamide—ABCB1—hematologic cancer	0.000228	0.13	CrCbGaD
Baclofen—Ibuprofen—ALB—hematologic cancer	0.000141	0.0803	CrCbGaD
Baclofen—Ibuprofen—ABCB1—hematologic cancer	0.000134	0.0766	CrCbGaD
Baclofen—GABBR1—Signaling Pathways—RGS2—hematologic cancer	6.03e-05	0.00102	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCR4—hematologic cancer	6.03e-05	0.00102	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TRIO—hematologic cancer	5.96e-05	0.00101	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TRH—hematologic cancer	5.96e-05	0.00101	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CMA1—hematologic cancer	5.96e-05	0.00101	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CBL—hematologic cancer	5.87e-05	0.000993	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ADCY7—hematologic cancer	5.86e-05	0.00099	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—HRAS—hematologic cancer	5.86e-05	0.00099	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AGO2—hematologic cancer	5.83e-05	0.000986	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SPHK1—hematologic cancer	5.83e-05	0.000986	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—NUP214—hematologic cancer	5.81e-05	0.000983	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL3—hematologic cancer	5.81e-05	0.000982	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LPAR1—hematologic cancer	5.77e-05	0.000976	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HDAC9—hematologic cancer	5.77e-05	0.000976	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CG—hematologic cancer	5.74e-05	0.000971	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—H3F3B—hematologic cancer	5.71e-05	0.000966	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTPN1—hematologic cancer	5.71e-05	0.000966	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCG2—hematologic cancer	5.7e-05	0.000963	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PTPN11—hematologic cancer	5.64e-05	0.000954	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—RASGRP1—hematologic cancer	5.62e-05	0.00095	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HSP90AA1—hematologic cancer	5.6e-05	0.000947	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SYK—hematologic cancer	5.6e-05	0.000947	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CD—hematologic cancer	5.56e-05	0.00094	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—GRB2—hematologic cancer	5.51e-05	0.000932	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CREB1—hematologic cancer	5.47e-05	0.000924	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CSF2—hematologic cancer	5.43e-05	0.000917	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT1—hematologic cancer	5.4e-05	0.000913	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL2—hematologic cancer	5.35e-05	0.000904	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6R—hematologic cancer	5.33e-05	0.000901	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDE4B—hematologic cancer	5.31e-05	0.000898	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CNR2—hematologic cancer	5.31e-05	0.000898	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF19—hematologic cancer	5.27e-05	0.000891	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3R1—hematologic cancer	5.25e-05	0.000887	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—JAK1—hematologic cancer	5.24e-05	0.000885	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PRKCG—hematologic cancer	5.24e-05	0.000885	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RAC2—hematologic cancer	5.23e-05	0.000883	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—DKK1—hematologic cancer	5.19e-05	0.000876	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT5B—hematologic cancer	5.15e-05	0.00087	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—JAK2—hematologic cancer	5.1e-05	0.000862	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAP2K1—hematologic cancer	5.08e-05	0.000859	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.08e-05	0.000858	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—GRB2—hematologic cancer	5.06e-05	0.000855	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CD—hematologic cancer	5.05e-05	0.000853	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFA—hematologic cancer	5.04e-05	0.000852	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADCY7—hematologic cancer	4.99e-05	0.000844	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KITLG—hematologic cancer	4.97e-05	0.00084	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CSF2—hematologic cancer	4.93e-05	0.000833	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2RA—hematologic cancer	4.89e-05	0.000827	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—STAT5A—hematologic cancer	4.86e-05	0.000821	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—XIAP—hematologic cancer	4.86e-05	0.000821	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CB—hematologic cancer	4.85e-05	0.000819	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN2B—hematologic cancer	4.82e-05	0.000814	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3R1—hematologic cancer	4.77e-05	0.000806	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—JAK1—hematologic cancer	4.76e-05	0.000804	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PRKCG—hematologic cancer	4.76e-05	0.000804	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SMARCA4—hematologic cancer	4.74e-05	0.0008	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SH2B3—hematologic cancer	4.74e-05	0.0008	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GZMB—hematologic cancer	4.71e-05	0.000795	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CD86—hematologic cancer	4.66e-05	0.000787	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—JAK2—hematologic cancer	4.63e-05	0.000783	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CTNNA1—hematologic cancer	4.59e-05	0.000777	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HES1—hematologic cancer	4.59e-05	0.000777	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NCOR1—hematologic cancer	4.57e-05	0.000772	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HSPB1—hematologic cancer	4.57e-05	0.000772	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EIF4EBP1—hematologic cancer	4.57e-05	0.000772	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL3—hematologic cancer	4.57e-05	0.000772	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTHLH—hematologic cancer	4.52e-05	0.000764	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SDC1—hematologic cancer	4.52e-05	0.000764	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF1—hematologic cancer	4.52e-05	0.000764	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CSF2—hematologic cancer	4.52e-05	0.000764	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—HRAS—hematologic cancer	4.49e-05	0.000758	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FOXO1—hematologic cancer	4.45e-05	0.000752	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—IL2—hematologic cancer	4.45e-05	0.000752	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFRB—hematologic cancer	4.44e-05	0.000751	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2RA—hematologic cancer	4.44e-05	0.000751	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CB—hematologic cancer	4.4e-05	0.000744	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTGER4—hematologic cancer	4.4e-05	0.000743	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.38e-05	0.00074	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LCK—hematologic cancer	4.37e-05	0.000739	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFRA—hematologic cancer	4.37e-05	0.000739	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PRKCG—hematologic cancer	4.36e-05	0.000737	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JAK1—hematologic cancer	4.36e-05	0.000737	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—H3F3A—hematologic cancer	4.29e-05	0.000725	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.26e-05	0.00072	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCZ—hematologic cancer	4.17e-05	0.000705	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CG—hematologic cancer	4.07e-05	0.000689	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2RA—hematologic cancer	4.07e-05	0.000688	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—hematologic cancer	4.04e-05	0.000683	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PARP1—hematologic cancer	4.03e-05	0.000681	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TERT—hematologic cancer	4.03e-05	0.000681	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FBXW7—hematologic cancer	3.96e-05	0.000669	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PDGFB—hematologic cancer	3.93e-05	0.000664	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HDAC2—hematologic cancer	3.88e-05	0.000657	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCR4—hematologic cancer	3.88e-05	0.000657	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TSC2—hematologic cancer	3.84e-05	0.000649	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CBL—hematologic cancer	3.79e-05	0.00064	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL3—hematologic cancer	3.75e-05	0.000633	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CG—hematologic cancer	3.7e-05	0.000625	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGFR3—hematologic cancer	3.69e-05	0.000624	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTPN1—hematologic cancer	3.68e-05	0.000622	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK14—hematologic cancer	3.66e-05	0.000618	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PTPN11—hematologic cancer	3.64e-05	0.000614	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—RASGRP1—hematologic cancer	3.62e-05	0.000612	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SYK—hematologic cancer	3.61e-05	0.00061	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HSP90AA1—hematologic cancer	3.61e-05	0.00061	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ESR1—hematologic cancer	3.59e-05	0.000607	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CD—hematologic cancer	3.58e-05	0.000605	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.56e-05	0.000601	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FN1—hematologic cancer	3.54e-05	0.000599	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CREB1—hematologic cancer	3.52e-05	0.000595	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NFKBIA—hematologic cancer	3.5e-05	0.000592	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BAD—hematologic cancer	3.5e-05	0.000592	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT1—hematologic cancer	3.48e-05	0.000589	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOTCH1—hematologic cancer	3.47e-05	0.000586	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL2—hematologic cancer	3.45e-05	0.000583	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6R—hematologic cancer	3.44e-05	0.000581	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CD80—hematologic cancer	3.4e-05	0.000574	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KIT—hematologic cancer	3.39e-05	0.000573	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CG—hematologic cancer	3.39e-05	0.000573	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—NRAS—hematologic cancer	3.39e-05	0.000573	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3R1—hematologic cancer	3.38e-05	0.000572	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PTPN11—hematologic cancer	3.33e-05	0.000563	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—JAK2—hematologic cancer	3.29e-05	0.000556	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—MAP2K1—hematologic cancer	3.27e-05	0.000553	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—GRB2—hematologic cancer	3.26e-05	0.000551	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CD—hematologic cancer	3.25e-05	0.00055	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFA—hematologic cancer	3.25e-05	0.000549	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—MAPK3—hematologic cancer	3.25e-05	0.000549	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CREB1—hematologic cancer	3.23e-05	0.000546	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KITLG—hematologic cancer	3.2e-05	0.000541	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—BRAF—hematologic cancer	3.19e-05	0.000539	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL2—hematologic cancer	3.16e-05	0.000534	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6R—hematologic cancer	3.15e-05	0.000532	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CREBBP—hematologic cancer	3.15e-05	0.000532	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT5A—hematologic cancer	3.13e-05	0.000529	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CB—hematologic cancer	3.12e-05	0.000528	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN2B—hematologic cancer	3.1e-05	0.000525	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3R1—hematologic cancer	3.07e-05	0.000519	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CD86—hematologic cancer	3e-05	0.000507	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAP2K1—hematologic cancer	3e-05	0.000507	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—JAK2—hematologic cancer	2.99e-05	0.000505	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CD—hematologic cancer	2.98e-05	0.000504	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HES1—hematologic cancer	2.96e-05	0.0005	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—PIK3CA—hematologic cancer	2.95e-05	0.000499	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NCOR1—hematologic cancer	2.94e-05	0.000498	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—KRAS—hematologic cancer	2.92e-05	0.000493	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGF1—hematologic cancer	2.91e-05	0.000492	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CSF2—hematologic cancer	2.91e-05	0.000492	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FOXO1—hematologic cancer	2.87e-05	0.000485	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2—hematologic cancer	2.87e-05	0.000485	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFRB—hematologic cancer	2.86e-05	0.000484	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FGF2—hematologic cancer	2.86e-05	0.000483	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—PIK3CB—hematologic cancer	2.84e-05	0.000479	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFRA—hematologic cancer	2.82e-05	0.000476	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3R1—hematologic cancer	2.82e-05	0.000476	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—JAK1—hematologic cancer	2.81e-05	0.000475	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PRKCG—hematologic cancer	2.81e-05	0.000475	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JAK2—hematologic cancer	2.74e-05	0.000463	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—PIK3CA—hematologic cancer	2.68e-05	0.000453	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MDM2—hematologic cancer	2.67e-05	0.000452	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2RA—hematologic cancer	2.62e-05	0.000443	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—hematologic cancer	2.6e-05	0.00044	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MTOR—hematologic cancer	2.6e-05	0.000439	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—PIK3CB—hematologic cancer	2.6e-05	0.000439	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TERT—hematologic cancer	2.59e-05	0.000439	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PDGFB—hematologic cancer	2.53e-05	0.000428	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—HRAS—hematologic cancer	2.48e-05	0.000419	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TSC2—hematologic cancer	2.48e-05	0.000418	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CDKN1B—hematologic cancer	2.44e-05	0.000412	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—AKT1—hematologic cancer	2.41e-05	0.000408	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CASP3—hematologic cancer	2.39e-05	0.000404	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—hematologic cancer	2.39e-05	0.000403	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—FGFR3—hematologic cancer	2.38e-05	0.000402	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.38e-05	0.000402	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—hematologic cancer	2.38e-05	0.000401	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MAPK14—hematologic cancer	2.36e-05	0.000398	CbGpPWpGaD
Baclofen—Pruritus—Etoposide—hematologic cancer	2.34e-05	8.38e-05	CcSEcCtD
Baclofen—Shock—Prednisone—hematologic cancer	2.34e-05	8.35e-05	CcSEcCtD
Baclofen—Arrhythmia—Epirubicin—hematologic cancer	2.33e-05	8.35e-05	CcSEcCtD
Baclofen—Pain—Dexamethasone—hematologic cancer	2.33e-05	8.34e-05	CcSEcCtD
Baclofen—Pain—Betamethasone—hematologic cancer	2.33e-05	8.34e-05	CcSEcCtD
Baclofen—Visual impairment—Doxorubicin—hematologic cancer	2.33e-05	8.34e-05	CcSEcCtD
Baclofen—Nervous system disorder—Prednisone—hematologic cancer	2.33e-05	8.33e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCND1—hematologic cancer	2.33e-05	0.000393	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—JUN—hematologic cancer	2.32e-05	0.000392	CbGpPWpGaD
Baclofen—Tachycardia—Prednisone—hematologic cancer	2.32e-05	8.29e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—ESR1—hematologic cancer	2.31e-05	0.000391	CbGpPWpGaD
Baclofen—Alopecia—Epirubicin—hematologic cancer	2.31e-05	8.26e-05	CcSEcCtD
Baclofen—Skin disorder—Prednisone—hematologic cancer	2.31e-05	8.25e-05	CcSEcCtD
Baclofen—Nausea—Gemcitabine—hematologic cancer	2.3e-05	8.24e-05	CcSEcCtD
Baclofen—Vomiting—Cisplatin—hematologic cancer	2.3e-05	8.22e-05	CcSEcCtD
Baclofen—Hyperhidrosis—Prednisone—hematologic cancer	2.29e-05	8.21e-05	CcSEcCtD
Baclofen—Vision blurred—Methotrexate—hematologic cancer	2.29e-05	8.2e-05	CcSEcCtD
Baclofen—Mental disorder—Epirubicin—hematologic cancer	2.29e-05	8.19e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FN1—hematologic cancer	2.28e-05	0.000386	CbGpPWpGaD
Baclofen—Rash—Cisplatin—hematologic cancer	2.28e-05	8.15e-05	CcSEcCtD
Baclofen—Dermatitis—Cisplatin—hematologic cancer	2.28e-05	8.15e-05	CcSEcCtD
Baclofen—Malnutrition—Epirubicin—hematologic cancer	2.27e-05	8.14e-05	CcSEcCtD
Baclofen—Diarrhoea—Etoposide—hematologic cancer	2.27e-05	8.11e-05	CcSEcCtD
Baclofen—Anorexia—Prednisone—hematologic cancer	2.26e-05	8.09e-05	CcSEcCtD
Baclofen—Eye disorder—Doxorubicin—hematologic cancer	2.26e-05	8.08e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—BAD—hematologic cancer	2.26e-05	0.000381	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NFKBIA—hematologic cancer	2.26e-05	0.000381	CbGpPWpGaD
Baclofen—Ill-defined disorder—Methotrexate—hematologic cancer	2.26e-05	8.07e-05	CcSEcCtD
Baclofen—Tinnitus—Doxorubicin—hematologic cancer	2.25e-05	8.06e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CDKN1A—hematologic cancer	2.25e-05	0.00038	CbGpPWpGaD
Baclofen—Anaemia—Methotrexate—hematologic cancer	2.25e-05	8.04e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PTEN—hematologic cancer	2.25e-05	0.00038	CbGpPWpGaD
Baclofen—Feeling abnormal—Betamethasone—hematologic cancer	2.25e-05	8.04e-05	CcSEcCtD
Baclofen—Feeling abnormal—Dexamethasone—hematologic cancer	2.25e-05	8.04e-05	CcSEcCtD
Baclofen—Flushing—Doxorubicin—hematologic cancer	2.24e-05	8.03e-05	CcSEcCtD
Baclofen—Cardiac disorder—Doxorubicin—hematologic cancer	2.24e-05	8.03e-05	CcSEcCtD
Baclofen—Flatulence—Epirubicin—hematologic cancer	2.24e-05	8.02e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—NOTCH1—hematologic cancer	2.24e-05	0.000378	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.23e-05	7.97e-05	CcSEcCtD
Baclofen—Gastrointestinal pain—Betamethasone—hematologic cancer	2.23e-05	7.97e-05	CcSEcCtD
Baclofen—Dysgeusia—Epirubicin—hematologic cancer	2.23e-05	7.97e-05	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—hematologic cancer	2.22e-05	0.000376	CbGpPWpGaD
Baclofen—Back pain—Epirubicin—hematologic cancer	2.2e-05	7.87e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MAPK8—hematologic cancer	2.2e-05	0.000371	CbGpPWpGaD
Baclofen—Angiopathy—Doxorubicin—hematologic cancer	2.19e-05	7.85e-05	CcSEcCtD
Baclofen—Malaise—Methotrexate—hematologic cancer	2.19e-05	7.84e-05	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—AKT1—hematologic cancer	2.19e-05	0.00037	CbGpPWpGaD
Baclofen—Dizziness—Etoposide—hematologic cancer	2.19e-05	7.83e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CD80—hematologic cancer	2.19e-05	0.00037	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KIT—hematologic cancer	2.19e-05	0.000369	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PIK3CG—hematologic cancer	2.19e-05	0.000369	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—NRAS—hematologic cancer	2.19e-05	0.000369	CbGpPWpGaD
Baclofen—Vertigo—Methotrexate—hematologic cancer	2.18e-05	7.81e-05	CcSEcCtD
Baclofen—Mediastinal disorder—Doxorubicin—hematologic cancer	2.18e-05	7.8e-05	CcSEcCtD
Baclofen—Chills—Doxorubicin—hematologic cancer	2.17e-05	7.76e-05	CcSEcCtD
Baclofen—Urticaria—Dexamethasone—hematologic cancer	2.17e-05	7.75e-05	CcSEcCtD
Baclofen—Urticaria—Betamethasone—hematologic cancer	2.17e-05	7.75e-05	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.16e-05	7.74e-05	CcSEcCtD
Baclofen—Dizziness—Prednisolone—hematologic cancer	2.16e-05	7.73e-05	CcSEcCtD
Baclofen—Arrhythmia—Doxorubicin—hematologic cancer	2.16e-05	7.73e-05	CcSEcCtD
Baclofen—Asthenia—Triamcinolone—hematologic cancer	2.16e-05	7.71e-05	CcSEcCtD
Baclofen—Abdominal pain—Betamethasone—hematologic cancer	2.15e-05	7.71e-05	CcSEcCtD
Baclofen—Body temperature increased—Betamethasone—hematologic cancer	2.15e-05	7.71e-05	CcSEcCtD
Baclofen—Body temperature increased—Dexamethasone—hematologic cancer	2.15e-05	7.71e-05	CcSEcCtD
Baclofen—Abdominal pain—Dexamethasone—hematologic cancer	2.15e-05	7.71e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PTPN11—hematologic cancer	2.15e-05	0.000363	CbGpPWpGaD
Baclofen—Nausea—Cisplatin—hematologic cancer	2.15e-05	7.68e-05	CcSEcCtD
Baclofen—Insomnia—Prednisone—hematologic cancer	2.15e-05	7.68e-05	CcSEcCtD
Baclofen—Vision blurred—Epirubicin—hematologic cancer	2.14e-05	7.67e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—EP300—hematologic cancer	2.14e-05	0.000362	CbGpPWpGaD
Baclofen—Alopecia—Doxorubicin—hematologic cancer	2.14e-05	7.64e-05	CcSEcCtD
Baclofen—Paraesthesia—Prednisone—hematologic cancer	2.13e-05	7.63e-05	CcSEcCtD
Baclofen—Pruritus—Triamcinolone—hematologic cancer	2.13e-05	7.6e-05	CcSEcCtD
Baclofen—Mental disorder—Doxorubicin—hematologic cancer	2.12e-05	7.58e-05	CcSEcCtD
Baclofen—Ill-defined disorder—Epirubicin—hematologic cancer	2.11e-05	7.55e-05	CcSEcCtD
Baclofen—Convulsion—Methotrexate—hematologic cancer	2.11e-05	7.53e-05	CcSEcCtD
Baclofen—Vomiting—Etoposide—hematologic cancer	2.11e-05	7.53e-05	CcSEcCtD
Baclofen—Malnutrition—Doxorubicin—hematologic cancer	2.1e-05	7.53e-05	CcSEcCtD
Baclofen—Anaemia—Epirubicin—hematologic cancer	2.1e-05	7.52e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—MAPK3—hematologic cancer	2.09e-05	0.000354	CbGpPWpGaD
Baclofen—Agitation—Epirubicin—hematologic cancer	2.09e-05	7.48e-05	CcSEcCtD
Baclofen—Dyspepsia—Prednisone—hematologic cancer	2.09e-05	7.47e-05	CcSEcCtD
Baclofen—Rash—Etoposide—hematologic cancer	2.09e-05	7.47e-05	CcSEcCtD
Baclofen—Dermatitis—Etoposide—hematologic cancer	2.09e-05	7.46e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—SRC—hematologic cancer	2.08e-05	0.000352	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CREB1—hematologic cancer	2.08e-05	0.000352	CbGpPWpGaD
Baclofen—Headache—Etoposide—hematologic cancer	2.07e-05	7.42e-05	CcSEcCtD
Baclofen—Flatulence—Doxorubicin—hematologic cancer	2.07e-05	7.42e-05	CcSEcCtD
Baclofen—Myalgia—Methotrexate—hematologic cancer	2.07e-05	7.4e-05	CcSEcCtD
Baclofen—Chest pain—Methotrexate—hematologic cancer	2.07e-05	7.4e-05	CcSEcCtD
Baclofen—Decreased appetite—Prednisone—hematologic cancer	2.06e-05	7.38e-05	CcSEcCtD
Baclofen—Dysgeusia—Doxorubicin—hematologic cancer	2.06e-05	7.37e-05	CcSEcCtD
Baclofen—Rash—Prednisolone—hematologic cancer	2.06e-05	7.37e-05	CcSEcCtD
Baclofen—Dermatitis—Prednisolone—hematologic cancer	2.06e-05	7.36e-05	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.06e-05	7.35e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—BRAF—hematologic cancer	2.05e-05	0.000347	CbGpPWpGaD
Baclofen—Malaise—Epirubicin—hematologic cancer	2.05e-05	7.34e-05	CcSEcCtD
Baclofen—Fatigue—Prednisone—hematologic cancer	2.05e-05	7.32e-05	CcSEcCtD
Baclofen—Headache—Prednisolone—hematologic cancer	2.05e-05	7.32e-05	CcSEcCtD
Baclofen—Discomfort—Methotrexate—hematologic cancer	2.04e-05	7.31e-05	CcSEcCtD
Baclofen—Vertigo—Epirubicin—hematologic cancer	2.04e-05	7.31e-05	CcSEcCtD
Baclofen—Syncope—Epirubicin—hematologic cancer	2.04e-05	7.3e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCL2—hematologic cancer	2.04e-05	0.000344	CbGpPWpGaD
Baclofen—Back pain—Doxorubicin—hematologic cancer	2.04e-05	7.28e-05	CcSEcCtD
Baclofen—Constipation—Prednisone—hematologic cancer	2.03e-05	7.26e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—IL6R—hematologic cancer	2.03e-05	0.000343	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—hematologic cancer	2.03e-05	0.000343	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CREBBP—hematologic cancer	2.03e-05	0.000343	CbGpPWpGaD
Baclofen—Palpitations—Epirubicin—hematologic cancer	2.01e-05	7.19e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—STAT3—hematologic cancer	2.01e-05	0.00034	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NRAS—hematologic cancer	2e-05	0.000339	CbGpPWpGaD
Baclofen—Confusional state—Methotrexate—hematologic cancer	2e-05	7.16e-05	CcSEcCtD
Baclofen—Loss of consciousness—Epirubicin—hematologic cancer	2e-05	7.15e-05	CcSEcCtD
Baclofen—Dizziness—Triamcinolone—hematologic cancer	1.99e-05	7.11e-05	CcSEcCtD
Baclofen—Vision blurred—Doxorubicin—hematologic cancer	1.98e-05	7.1e-05	CcSEcCtD
Baclofen—Convulsion—Epirubicin—hematologic cancer	1.97e-05	7.05e-05	CcSEcCtD
Baclofen—Infection—Methotrexate—hematologic cancer	1.97e-05	7.05e-05	CcSEcCtD
Baclofen—Nausea—Etoposide—hematologic cancer	1.97e-05	7.04e-05	CcSEcCtD
Baclofen—Hypertension—Epirubicin—hematologic cancer	1.96e-05	7.03e-05	CcSEcCtD
Baclofen—Feeling abnormal—Prednisone—hematologic cancer	1.96e-05	7e-05	CcSEcCtD
Baclofen—Asthenia—Betamethasone—hematologic cancer	1.96e-05	7e-05	CcSEcCtD
Baclofen—Asthenia—Dexamethasone—hematologic cancer	1.96e-05	7e-05	CcSEcCtD
Baclofen—Ill-defined disorder—Doxorubicin—hematologic cancer	1.95e-05	6.99e-05	CcSEcCtD
Baclofen—Nervous system disorder—Methotrexate—hematologic cancer	1.95e-05	6.96e-05	CcSEcCtD
Baclofen—Anaemia—Doxorubicin—hematologic cancer	1.95e-05	6.96e-05	CcSEcCtD
Baclofen—Gastrointestinal pain—Prednisone—hematologic cancer	1.94e-05	6.94e-05	CcSEcCtD
Baclofen—Nausea—Prednisolone—hematologic cancer	1.94e-05	6.94e-05	CcSEcCtD
Baclofen—Chest pain—Epirubicin—hematologic cancer	1.94e-05	6.93e-05	CcSEcCtD
Baclofen—Myalgia—Epirubicin—hematologic cancer	1.94e-05	6.93e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MAP2K1—hematologic cancer	1.93e-05	0.000327	CbGpPWpGaD
Baclofen—Agitation—Doxorubicin—hematologic cancer	1.93e-05	6.92e-05	CcSEcCtD
Baclofen—Anxiety—Epirubicin—hematologic cancer	1.93e-05	6.9e-05	CcSEcCtD
Baclofen—Pruritus—Betamethasone—hematologic cancer	1.93e-05	6.9e-05	CcSEcCtD
Baclofen—Pruritus—Dexamethasone—hematologic cancer	1.93e-05	6.9e-05	CcSEcCtD
Baclofen—Skin disorder—Methotrexate—hematologic cancer	1.93e-05	6.89e-05	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	1.92e-05	6.88e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PIK3CD—hematologic cancer	1.92e-05	0.000325	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MAPK3—hematologic cancer	1.92e-05	0.000324	CbGpPWpGaD
Baclofen—Hyperhidrosis—Methotrexate—hematologic cancer	1.92e-05	6.86e-05	CcSEcCtD
Baclofen—Discomfort—Epirubicin—hematologic cancer	1.91e-05	6.84e-05	CcSEcCtD
Baclofen—Vomiting—Triamcinolone—hematologic cancer	1.91e-05	6.83e-05	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PIK3CA—hematologic cancer	1.9e-05	0.000322	CbGpPWpGaD
Baclofen—Malaise—Doxorubicin—hematologic cancer	1.9e-05	6.79e-05	CcSEcCtD
Baclofen—Rash—Triamcinolone—hematologic cancer	1.89e-05	6.78e-05	CcSEcCtD
Baclofen—Dry mouth—Epirubicin—hematologic cancer	1.89e-05	6.78e-05	CcSEcCtD
Baclofen—Dermatitis—Triamcinolone—hematologic cancer	1.89e-05	6.77e-05	CcSEcCtD
Baclofen—Vertigo—Doxorubicin—hematologic cancer	1.89e-05	6.76e-05	CcSEcCtD
Baclofen—Anorexia—Methotrexate—hematologic cancer	1.89e-05	6.76e-05	CcSEcCtD
Baclofen—Syncope—Doxorubicin—hematologic cancer	1.89e-05	6.75e-05	CcSEcCtD
Baclofen—Urticaria—Prednisone—hematologic cancer	1.89e-05	6.75e-05	CcSEcCtD
Baclofen—Headache—Triamcinolone—hematologic cancer	1.88e-05	6.73e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—KRAS—hematologic cancer	1.88e-05	0.000318	CbGpPWpGaD
Baclofen—Abdominal pain—Prednisone—hematologic cancer	1.88e-05	6.71e-05	CcSEcCtD
Baclofen—Body temperature increased—Prednisone—hematologic cancer	1.88e-05	6.71e-05	CcSEcCtD
Baclofen—Confusional state—Epirubicin—hematologic cancer	1.87e-05	6.7e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—MYC—hematologic cancer	1.87e-05	0.000315	CbGpPWpGaD
Baclofen—Diarrhoea—Dexamethasone—hematologic cancer	1.86e-05	6.67e-05	CcSEcCtD
Baclofen—Diarrhoea—Betamethasone—hematologic cancer	1.86e-05	6.67e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—TGFB1—hematologic cancer	1.86e-05	0.000315	CbGpPWpGaD
Baclofen—Palpitations—Doxorubicin—hematologic cancer	1.86e-05	6.65e-05	CcSEcCtD
Baclofen—Oedema—Epirubicin—hematologic cancer	1.86e-05	6.64e-05	CcSEcCtD
Baclofen—Hypotension—Methotrexate—hematologic cancer	1.85e-05	6.63e-05	CcSEcCtD
Baclofen—Loss of consciousness—Doxorubicin—hematologic cancer	1.85e-05	6.62e-05	CcSEcCtD
Baclofen—Infection—Epirubicin—hematologic cancer	1.84e-05	6.6e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FGF2—hematologic cancer	1.84e-05	0.000311	CbGpPWpGaD
Baclofen—Shock—Epirubicin—hematologic cancer	1.83e-05	6.53e-05	CcSEcCtD
Baclofen—Convulsion—Doxorubicin—hematologic cancer	1.82e-05	6.52e-05	CcSEcCtD
Baclofen—Nervous system disorder—Epirubicin—hematologic cancer	1.82e-05	6.51e-05	CcSEcCtD
Baclofen—Hypertension—Doxorubicin—hematologic cancer	1.82e-05	6.5e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PIK3R1—hematologic cancer	1.81e-05	0.000307	CbGpPWpGaD
Baclofen—Tachycardia—Epirubicin—hematologic cancer	1.81e-05	6.48e-05	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.81e-05	6.47e-05	CcSEcCtD
Baclofen—Skin disorder—Epirubicin—hematologic cancer	1.8e-05	6.45e-05	CcSEcCtD
Baclofen—Dizziness—Betamethasone—hematologic cancer	1.8e-05	6.45e-05	CcSEcCtD
Baclofen—Dizziness—Dexamethasone—hematologic cancer	1.8e-05	6.45e-05	CcSEcCtD
Baclofen—Hyperhidrosis—Epirubicin—hematologic cancer	1.79e-05	6.42e-05	CcSEcCtD
Baclofen—Insomnia—Methotrexate—hematologic cancer	1.79e-05	6.42e-05	CcSEcCtD
Baclofen—Myalgia—Doxorubicin—hematologic cancer	1.79e-05	6.41e-05	CcSEcCtD
Baclofen—Chest pain—Doxorubicin—hematologic cancer	1.79e-05	6.41e-05	CcSEcCtD
Baclofen—Anxiety—Doxorubicin—hematologic cancer	1.79e-05	6.39e-05	CcSEcCtD
Baclofen—Nausea—Triamcinolone—hematologic cancer	1.78e-05	6.38e-05	CcSEcCtD
Baclofen—Paraesthesia—Methotrexate—hematologic cancer	1.78e-05	6.37e-05	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.78e-05	6.37e-05	CcSEcCtD
Baclofen—Discomfort—Doxorubicin—hematologic cancer	1.77e-05	6.33e-05	CcSEcCtD
Baclofen—Anorexia—Epirubicin—hematologic cancer	1.77e-05	6.33e-05	CcSEcCtD
Baclofen—Dyspnoea—Methotrexate—hematologic cancer	1.77e-05	6.33e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—JAK2—hematologic cancer	1.76e-05	0.000298	CbGpPWpGaD
Baclofen—Somnolence—Methotrexate—hematologic cancer	1.76e-05	6.31e-05	CcSEcCtD
Baclofen—Dry mouth—Doxorubicin—hematologic cancer	1.75e-05	6.27e-05	CcSEcCtD
Baclofen—Dyspepsia—Methotrexate—hematologic cancer	1.75e-05	6.25e-05	CcSEcCtD
Baclofen—Hypotension—Epirubicin—hematologic cancer	1.73e-05	6.21e-05	CcSEcCtD
Baclofen—Vomiting—Betamethasone—hematologic cancer	1.73e-05	6.2e-05	CcSEcCtD
Baclofen—Vomiting—Dexamethasone—hematologic cancer	1.73e-05	6.2e-05	CcSEcCtD
Baclofen—Confusional state—Doxorubicin—hematologic cancer	1.73e-05	6.2e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PIK3CA—hematologic cancer	1.73e-05	0.000292	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KRAS—hematologic cancer	1.72e-05	0.000292	CbGpPWpGaD
Baclofen—Decreased appetite—Methotrexate—hematologic cancer	1.72e-05	6.17e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MDM2—hematologic cancer	1.72e-05	0.000291	CbGpPWpGaD
Baclofen—Rash—Dexamethasone—hematologic cancer	1.72e-05	6.15e-05	CcSEcCtD
Baclofen—Rash—Betamethasone—hematologic cancer	1.72e-05	6.15e-05	CcSEcCtD
Baclofen—Oedema—Doxorubicin—hematologic cancer	1.72e-05	6.15e-05	CcSEcCtD
Baclofen—Dermatitis—Dexamethasone—hematologic cancer	1.72e-05	6.14e-05	CcSEcCtD
Baclofen—Dermatitis—Betamethasone—hematologic cancer	1.72e-05	6.14e-05	CcSEcCtD
Baclofen—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.71e-05	6.13e-05	CcSEcCtD
Baclofen—Fatigue—Methotrexate—hematologic cancer	1.71e-05	6.12e-05	CcSEcCtD
Baclofen—Headache—Dexamethasone—hematologic cancer	1.71e-05	6.11e-05	CcSEcCtD
Baclofen—Headache—Betamethasone—hematologic cancer	1.71e-05	6.11e-05	CcSEcCtD
Baclofen—Infection—Doxorubicin—hematologic cancer	1.71e-05	6.1e-05	CcSEcCtD
Baclofen—Asthenia—Prednisone—hematologic cancer	1.7e-05	6.09e-05	CcSEcCtD
Baclofen—Pain—Methotrexate—hematologic cancer	1.7e-05	6.07e-05	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.69e-05	6.05e-05	CcSEcCtD
Baclofen—Shock—Doxorubicin—hematologic cancer	1.69e-05	6.05e-05	CcSEcCtD
Baclofen—Nervous system disorder—Doxorubicin—hematologic cancer	1.68e-05	6.03e-05	CcSEcCtD
Baclofen—Pruritus—Prednisone—hematologic cancer	1.68e-05	6.01e-05	CcSEcCtD
Baclofen—Insomnia—Epirubicin—hematologic cancer	1.68e-05	6.01e-05	CcSEcCtD
Baclofen—Tachycardia—Doxorubicin—hematologic cancer	1.68e-05	6e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PIK3CB—hematologic cancer	1.67e-05	0.000283	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MTOR—hematologic cancer	1.67e-05	0.000283	CbGpPWpGaD
Baclofen—Skin disorder—Doxorubicin—hematologic cancer	1.67e-05	5.97e-05	CcSEcCtD
Baclofen—Paraesthesia—Epirubicin—hematologic cancer	1.67e-05	5.96e-05	CcSEcCtD
Baclofen—Hyperhidrosis—Doxorubicin—hematologic cancer	1.66e-05	5.94e-05	CcSEcCtD
Baclofen—Dyspnoea—Epirubicin—hematologic cancer	1.66e-05	5.92e-05	CcSEcCtD
Baclofen—Somnolence—Epirubicin—hematologic cancer	1.65e-05	5.9e-05	CcSEcCtD
Baclofen—Anorexia—Doxorubicin—hematologic cancer	1.64e-05	5.86e-05	CcSEcCtD
Baclofen—Feeling abnormal—Methotrexate—hematologic cancer	1.63e-05	5.85e-05	CcSEcCtD
Baclofen—Dyspepsia—Epirubicin—hematologic cancer	1.63e-05	5.85e-05	CcSEcCtD
Baclofen—Diarrhoea—Prednisone—hematologic cancer	1.62e-05	5.81e-05	CcSEcCtD
Baclofen—Gastrointestinal pain—Methotrexate—hematologic cancer	1.62e-05	5.8e-05	CcSEcCtD
Baclofen—Nausea—Dexamethasone—hematologic cancer	1.62e-05	5.79e-05	CcSEcCtD
Baclofen—Nausea—Betamethasone—hematologic cancer	1.62e-05	5.79e-05	CcSEcCtD
Baclofen—Decreased appetite—Epirubicin—hematologic cancer	1.61e-05	5.77e-05	CcSEcCtD
Baclofen—Hypotension—Doxorubicin—hematologic cancer	1.61e-05	5.74e-05	CcSEcCtD
Baclofen—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.6e-05	5.73e-05	CcSEcCtD
Baclofen—Fatigue—Epirubicin—hematologic cancer	1.6e-05	5.73e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—HRAS—hematologic cancer	1.6e-05	0.00027	CbGpPWpGaD
Baclofen—Pain—Epirubicin—hematologic cancer	1.59e-05	5.68e-05	CcSEcCtD
Baclofen—Constipation—Epirubicin—hematologic cancer	1.59e-05	5.68e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PIK3CA—hematologic cancer	1.58e-05	0.000268	CbGpPWpGaD
Baclofen—Urticaria—Methotrexate—hematologic cancer	1.58e-05	5.64e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CDKN1B—hematologic cancer	1.57e-05	0.000266	CbGpPWpGaD
Baclofen—Dizziness—Prednisone—hematologic cancer	1.57e-05	5.62e-05	CcSEcCtD
Baclofen—Abdominal pain—Methotrexate—hematologic cancer	1.57e-05	5.61e-05	CcSEcCtD
Baclofen—Body temperature increased—Methotrexate—hematologic cancer	1.57e-05	5.61e-05	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.56e-05	5.6e-05	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—AKT1—hematologic cancer	1.55e-05	0.000263	CbGpPWpGaD
Baclofen—Insomnia—Doxorubicin—hematologic cancer	1.55e-05	5.56e-05	CcSEcCtD
Baclofen—Paraesthesia—Doxorubicin—hematologic cancer	1.54e-05	5.52e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CASP3—hematologic cancer	1.54e-05	0.00026	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—hematologic cancer	1.54e-05	0.00026	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—hematologic cancer	1.53e-05	0.000259	CbGpPWpGaD
Baclofen—Dyspnoea—Doxorubicin—hematologic cancer	1.53e-05	5.48e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—IL6—hematologic cancer	1.53e-05	0.000259	CbGpPWpGaD
Baclofen—Feeling abnormal—Epirubicin—hematologic cancer	1.53e-05	5.47e-05	CcSEcCtD
Baclofen—Somnolence—Doxorubicin—hematologic cancer	1.53e-05	5.46e-05	CcSEcCtD
Baclofen—Gastrointestinal pain—Epirubicin—hematologic cancer	1.52e-05	5.43e-05	CcSEcCtD
Baclofen—Dyspepsia—Doxorubicin—hematologic cancer	1.51e-05	5.41e-05	CcSEcCtD
Baclofen—Vomiting—Prednisone—hematologic cancer	1.51e-05	5.4e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCND1—hematologic cancer	1.5e-05	0.000253	CbGpPWpGaD
Baclofen—Rash—Prednisone—hematologic cancer	1.5e-05	5.35e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—JUN—hematologic cancer	1.5e-05	0.000253	CbGpPWpGaD
Baclofen—Dermatitis—Prednisone—hematologic cancer	1.5e-05	5.35e-05	CcSEcCtD
Baclofen—Decreased appetite—Doxorubicin—hematologic cancer	1.49e-05	5.34e-05	CcSEcCtD
Baclofen—Headache—Prednisone—hematologic cancer	1.49e-05	5.32e-05	CcSEcCtD
Baclofen—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.48e-05	5.31e-05	CcSEcCtD
Baclofen—Fatigue—Doxorubicin—hematologic cancer	1.48e-05	5.3e-05	CcSEcCtD
Baclofen—Urticaria—Epirubicin—hematologic cancer	1.47e-05	5.28e-05	CcSEcCtD
Baclofen—Constipation—Doxorubicin—hematologic cancer	1.47e-05	5.25e-05	CcSEcCtD
Baclofen—Pain—Doxorubicin—hematologic cancer	1.47e-05	5.25e-05	CcSEcCtD
Baclofen—Body temperature increased—Epirubicin—hematologic cancer	1.47e-05	5.25e-05	CcSEcCtD
Baclofen—Abdominal pain—Epirubicin—hematologic cancer	1.47e-05	5.25e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HRAS—hematologic cancer	1.47e-05	0.000248	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CDKN1A—hematologic cancer	1.45e-05	0.000245	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—PTEN—hematologic cancer	1.45e-05	0.000245	CbGpPWpGaD
Baclofen—Asthenia—Methotrexate—hematologic cancer	1.42e-05	5.09e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MAPK8—hematologic cancer	1.42e-05	0.000239	CbGpPWpGaD
Baclofen—Feeling abnormal—Doxorubicin—hematologic cancer	1.42e-05	5.06e-05	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—AKT1—hematologic cancer	1.41e-05	0.000239	CbGpPWpGaD
Baclofen—Nausea—Prednisone—hematologic cancer	1.41e-05	5.04e-05	CcSEcCtD
Baclofen—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.4e-05	5.03e-05	CcSEcCtD
Baclofen—Pruritus—Methotrexate—hematologic cancer	1.4e-05	5.02e-05	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—IL6—hematologic cancer	1.4e-05	0.000237	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EP300—hematologic cancer	1.38e-05	0.000233	CbGpPWpGaD
Baclofen—Urticaria—Doxorubicin—hematologic cancer	1.36e-05	4.88e-05	CcSEcCtD
Baclofen—Abdominal pain—Doxorubicin—hematologic cancer	1.36e-05	4.86e-05	CcSEcCtD
Baclofen—Body temperature increased—Doxorubicin—hematologic cancer	1.36e-05	4.86e-05	CcSEcCtD
Baclofen—Diarrhoea—Methotrexate—hematologic cancer	1.36e-05	4.86e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—SRC—hematologic cancer	1.34e-05	0.000227	CbGpPWpGaD
Baclofen—Asthenia—Epirubicin—hematologic cancer	1.33e-05	4.77e-05	CcSEcCtD
Baclofen—Pruritus—Epirubicin—hematologic cancer	1.31e-05	4.7e-05	CcSEcCtD
Baclofen—Dizziness—Methotrexate—hematologic cancer	1.31e-05	4.69e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—VEGFA—hematologic cancer	1.31e-05	0.000221	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—AKT1—hematologic cancer	1.29e-05	0.000219	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—STAT3—hematologic cancer	1.29e-05	0.000219	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NRAS—hematologic cancer	1.29e-05	0.000218	CbGpPWpGaD
Baclofen—Diarrhoea—Epirubicin—hematologic cancer	1.27e-05	4.54e-05	CcSEcCtD
Baclofen—Vomiting—Methotrexate—hematologic cancer	1.26e-05	4.51e-05	CcSEcCtD
Baclofen—Rash—Methotrexate—hematologic cancer	1.25e-05	4.47e-05	CcSEcCtD
Baclofen—Dermatitis—Methotrexate—hematologic cancer	1.25e-05	4.47e-05	CcSEcCtD
Baclofen—Headache—Methotrexate—hematologic cancer	1.24e-05	4.45e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MAPK3—hematologic cancer	1.24e-05	0.000209	CbGpPWpGaD
Baclofen—Asthenia—Doxorubicin—hematologic cancer	1.23e-05	4.41e-05	CcSEcCtD
Baclofen—Dizziness—Epirubicin—hematologic cancer	1.23e-05	4.39e-05	CcSEcCtD
Baclofen—Pruritus—Doxorubicin—hematologic cancer	1.22e-05	4.35e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—MYC—hematologic cancer	1.2e-05	0.000203	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—hematologic cancer	1.2e-05	0.000203	CbGpPWpGaD
Baclofen—Vomiting—Epirubicin—hematologic cancer	1.18e-05	4.22e-05	CcSEcCtD
Baclofen—Nausea—Methotrexate—hematologic cancer	1.18e-05	4.22e-05	CcSEcCtD
Baclofen—Diarrhoea—Doxorubicin—hematologic cancer	1.18e-05	4.2e-05	CcSEcCtD
Baclofen—Rash—Epirubicin—hematologic cancer	1.17e-05	4.19e-05	CcSEcCtD
Baclofen—Dermatitis—Epirubicin—hematologic cancer	1.17e-05	4.18e-05	CcSEcCtD
Baclofen—Headache—Epirubicin—hematologic cancer	1.16e-05	4.16e-05	CcSEcCtD
Baclofen—Dizziness—Doxorubicin—hematologic cancer	1.14e-05	4.06e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—KRAS—hematologic cancer	1.11e-05	0.000188	CbGpPWpGaD
Baclofen—Nausea—Epirubicin—hematologic cancer	1.1e-05	3.94e-05	CcSEcCtD
Baclofen—Vomiting—Doxorubicin—hematologic cancer	1.09e-05	3.91e-05	CcSEcCtD
Baclofen—Rash—Doxorubicin—hematologic cancer	1.08e-05	3.87e-05	CcSEcCtD
Baclofen—Dermatitis—Doxorubicin—hematologic cancer	1.08e-05	3.87e-05	CcSEcCtD
Baclofen—Headache—Doxorubicin—hematologic cancer	1.08e-05	3.85e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PIK3CA—hematologic cancer	1.02e-05	0.000173	CbGpPWpGaD
Baclofen—Nausea—Doxorubicin—hematologic cancer	1.02e-05	3.65e-05	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—TP53—hematologic cancer	9.88e-06	0.000167	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HRAS—hematologic cancer	9.45e-06	0.00016	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—hematologic cancer	9.04e-06	0.000153	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—AKT1—hematologic cancer	8.34e-06	0.000141	CbGpPWpGaD
